Home » Moderna’s cancer shot: exciting for investors, inconclusive for patients

Moderna’s cancer shot: exciting for investors, inconclusive for patients

Moderna’s cancer shot: exciting for investors, inconclusive for patients

This post was originally published on this site.

A glimmer of hope for sufferers, a potential revenue platform for a cash-burner, and a whole heap of unknowns